CA2157359A1 - Nouveau derives o-sulfates de gangliosides et de lysoganglioside - Google Patents

Nouveau derives o-sulfates de gangliosides et de lysoganglioside

Info

Publication number
CA2157359A1
CA2157359A1 CA002157359A CA2157359A CA2157359A1 CA 2157359 A1 CA2157359 A1 CA 2157359A1 CA 002157359 A CA002157359 A CA 002157359A CA 2157359 A CA2157359 A CA 2157359A CA 2157359 A1 CA2157359 A1 CA 2157359A1
Authority
CA
Canada
Prior art keywords
lyso
dilyso
acyl
derivatives
gangliosides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002157359A
Other languages
English (en)
Inventor
Aurelio Romeo
Gunter Kirschner
Carlo Chizzolini
Hari Manev
Laura Facci
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fidia SpA
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2157359A1 publication Critical patent/CA2157359A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • C07H15/10—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical containing unsaturated carbon-to-carbon bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7032—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a polyol, i.e. compounds having two or more free or esterified hydroxy groups, including the hydroxy group involved in the glycosidic linkage, e.g. monoglucosyldiacylglycerides, lactobionic acid, gangliosides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Oncology (AREA)
  • Immunology (AREA)
  • Vascular Medicine (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
CA002157359A 1993-03-04 1994-03-04 Nouveau derives o-sulfates de gangliosides et de lysoganglioside Abandoned CA2157359A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT93PD000045A IT1267956B1 (it) 1993-03-04 1993-03-04 Derivati o-solfatati di gangliosidi e lisogangliosidi
ITPD93A000045 1993-03-04

Publications (1)

Publication Number Publication Date
CA2157359A1 true CA2157359A1 (fr) 1994-09-15

Family

ID=11390210

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002157359A Abandoned CA2157359A1 (fr) 1993-03-04 1994-03-04 Nouveau derives o-sulfates de gangliosides et de lysoganglioside

Country Status (10)

Country Link
EP (1) EP0688330B1 (fr)
JP (1) JPH08507307A (fr)
KR (1) KR960701073A (fr)
AT (1) ATE204287T1 (fr)
AU (1) AU694105B2 (fr)
CA (1) CA2157359A1 (fr)
DE (1) DE69427966T2 (fr)
ES (1) ES2159554T3 (fr)
IT (1) IT1267956B1 (fr)
WO (1) WO1994020515A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1267955B1 (it) * 1993-03-04 1997-02-18 Fidia S P A In Amministrazione Derivati solfatati dei lisogangliosidi
WO2012004917A1 (fr) 2010-07-06 2012-01-12 Kaminishi Hidenori Agent d'excroissance des neurites

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1238346B (it) * 1989-11-14 1993-07-13 Gangliosidi modificati e loro derivati funzionali.
JPH03246297A (ja) * 1990-02-22 1991-11-01 Nippon Koutai Kenkyusho:Kk ガングリオシド誘導体及びこれを含有する抗ｈｉｖ剤
IT1253832B (it) * 1991-08-01 1995-08-29 Fidia Spa Derivati di gangliosidi

Also Published As

Publication number Publication date
KR960701073A (ko) 1996-02-24
ATE204287T1 (de) 2001-09-15
EP0688330A1 (fr) 1995-12-27
ITPD930045A1 (it) 1994-09-04
AU694105B2 (en) 1998-07-16
WO1994020515A1 (fr) 1994-09-15
ITPD930045A0 (it) 1993-03-04
ES2159554T3 (es) 2001-10-16
DE69427966D1 (de) 2001-09-20
EP0688330B1 (fr) 2001-08-16
JPH08507307A (ja) 1996-08-06
IT1267956B1 (it) 1997-02-18
DE69427966T2 (de) 2002-04-04
AU6352194A (en) 1994-09-26

Similar Documents

Publication Publication Date Title
US6110897A (en) Antiinflammatory cell adhesion inhibitors
EP0433112B1 (fr) Gangliosides modifiés et leurs dérivés fonctionnels
HU199860B (en) Process for producing ganglioside derivatives and pharmaceutical compositions comprising such active ingredient
US20050187171A1 (en) Glycomimetic antagonists for both E-and P-selectins
EP0373038A2 (fr) Dérivés de lysosphingolipides
WO2008059307A2 (fr) Bêta 1,6 glucosamine disaccharides fonctionnalisés et leur procédé de préparation
EP0410881B1 (fr) Analogues semi-synthétiques de gangliosides
US5849717A (en) O-sulfated gangliosides and lyso-ganglioside derivatives
US5795869A (en) Sulfated lyso-ganglioside derivatives
EP0373039B1 (fr) Dérivés de lysogangliosides
EP0688330B1 (fr) Nouveaux gangliosides o-sulfates et derives de lygo-ganglioside
EP0410883B1 (fr) Dérivés de di-lysogangliosides
Bulusu et al. Acyclic analogs of lipid A: synthesis and biological activities.
EP0688331B1 (fr) Nouveaux derives sulfates de lyso-gangliosides
US6407072B1 (en) Lysoganglioside derivatives
KR100473325B1 (ko) 항바이러스활성을가진신규화합물
EP1140961A1 (fr) Procede relatif a l'elaboration de ganglioside gm3 par hydrolyse acide d'esters internes de ganglioside, et utilisation dans le domaine pharmaceutique

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued